The inhibition of α-glucosidase and glucose-6-phosphatase, two enzymes involved in the carbohydrate metabolism, is an important target to control glycaemia on individuals with type 2 diabetes. This evidence concerns the gene G6PC1 and type 2 diabetes mellitus.